PAREXEL International Corporation (PRXL) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

PAREXEL International Corporation Company Snapshot

Business Description:

PAREXEL International Corporation operates in the Commercial physical research sector. PAREXEL International Corporation is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services, PAREXEL Consulting and MedCom Services and Perceptive Informatics, Inc. Its products and service offerings include clinical trials management, data management, biostatistical analysis, medical communications, clinical pharmacology, patient recruitment, regulatory and product development consulting, health policy and reimbursement, performance improvement, industry training and publishing, medical imaging services, ClinPhone randomization and trial supply management services, electronic data capture systems, clinical trial management systems, Web-based portals, systems integration, patient diary applications, and other drug development services. In our complete report available for purchase the company is compared to: Pharmaceutical Product Development, Incorporated, Charles River Laboratories International Inc and Covance Inc..

PAREXEL International Corporation

Stock Performance Chart for PAREXEL International Corporation

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 24.15
(Figures in U.S. Dollars)

1 Week	-2.6%		13 Weeks	16.4%

4 Weeks	19.1%		52 Weeks	11.6%

PAREXEL International Corporation Key Data:

	Ticker:	PRXL	Country:	UNITED STATES

	Exchanges:	NAS	Major Industry:	Miscellaneous

			Sub Industry:	Medical Services

	2011 Sales	1,422,425,000 (Year Ending Jan 2012).	Employees:	10,550

	Currency:	U.S. Dollars	Market Cap:	1,428,837,696

	Fiscal Yr Ends:	June	Shares Outstanding:	59,165,122

	Share Type:	Common	Closely Held Shares:	9,744,184

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.